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ABSTRACT
Objectives: The values of white blood cell types were evaluated to determine which one is the most potential index in the diagnosis of patients with 
ischemic stroke (IS). Besides, neutrophil-lymphocyte ratio, neutrophil-to-monocyte ratio, and lymphocyte-to-monocyte ratio (LMR) were determined 
to confirm whether there is a relationship between these parameters and stroke.
Methods: One thousand files of patients admitted between January 2017 and March 2020 to intensive care units at Alia Governmental Hospital in 
Hebron-Palestine were reviewed and evaluated. Only a total of 87 patients were found to meet our inclusion criteria and included in the study and 
a total of 913 patients were excluded. Besides, complete blood counts of a total of 95 patients’ data were also collected randomly from Private Lab 
in Hebron district, and were considered as healthy individuals (HI); that is, a control group. The data were introduced to the excel program 2010 
version to facilitate reading and analysis. GraphPad Prism version (8.3.4.) was used to analyze the data. The data of patients and HI were compared to 
determine which value/s of these blood components is associated with the risk of stroke.
Results: Different types of white blood cells; monocytes, lymphocytes, and neutrophils for stroke and healthy patients were collected and 
compared. Besides, the platelet count was also compared. It was found a marked significant decrease in the monocytes counts in all stroke patients 
(100–1500 cell/ul) compare to monocytes counts in the healthy donors (310–1740 cell/ul). Lymphocytes were also significantly decreased among 
all stroke patients (300–8600 cells/ul) compare to HI (910–9000 cells/ul). There was no significant increase in neutrophils in stroke patients. The 
ratios of neutrophils to monocytes and neutrophils to lymphocytes in stroke patients were compared too. The results showed a significantly elevated 
neutrophil ratio compare to monocytes and lymphocytes in all stroke patients. The platelet counts in stroke patients were also found less compared 
to HI. The percentages of these blood components were also evaluated.
Conclusion: It is demonstrated that patients with stroke have lower lymphocyte and higher monocyte counts, and therefore, lower LMR values 
compared to the control group. It was found that MLR was significantly correlated with IS. LMR is associated with functional outcomes in patients 
with stroke.
Keywords: Lymphocyte-to-monocyte ratio, Acute ischemic stroke, Stroke severity, Prognosis, Neutrophil to monocyte.
INTRODUCTION
Stroke is the third leading cause of death and a major cause of disability 
in Western countries. Ischemic stroke (IS) is the most common 
type of stroke and is about 80% of all strokes [1]. Inflammation is a 
cellular response to protect the body against harmful things, such as 
infections, injuries, and toxins. When something damages the cells, the 
body releases chemicals that trigger a response of the body’s immune 
system. IS is one of the main causes of mortality and morbidity in the 
world. The occlusion of cerebral arteries in IS patients is the most 
common cause of emergency admission. IS accounts for 80–85% of all 
cerebrovascular diseases as mentioned [2]. IS releases a very complex 
cascade of molecular and cellular effects that are related to each 
other [3]. The inflammatory response is one of the major critical factors 
contributing to the pathophysiological process of IS. There are different 
inflammatory markers such as C-reactive protein (CRP) and fibrinogen 
used for the prognosis of IS [3]. It was indicated that elevated plasma 
levels of inflammatory cytokines, CRP, and chemokines are associated 
with future cardiovascular risk [4]. Plasma levels of soluble intercellular 
adhesion molecule-1 (sICAM-1) and sE-selectin were observed to be 
increased both in large intracranial artery disease and small artery 
disease [5]. Plasma levels of ICAM-1 and monocyte chemoattractant 
protein-1 (MCP-1) were noted to be high in patients with IS and 
myocardial infarction [6,7]. Thus, it has been suggested that white 
blood cell subtypes can also be used as a marker of inflammation [8]. It 
has been indicated that lymphocyte count may decrease in IS patients 
after ischemia [8,9]. It is thought that the suppression of lymphocyte 
count can be secondary to lymphocyte apoptosis and redistribution 
of lymphocytes to lymphatic organs which are induced by stress after 
ischemia. It has also been revealed that the decrease in lymphocyte 
count is associated with poor prognosis after IS and gives a negative 
role in long-term functional recovery. It is considered that microglial 
cells located throughout the brain are activated rapidly after ischemia 
and are the major cells that contribute to inflammation after injury. 
However, for many years, clinical observations showed that plasma 
levels of inflammatory cytokines were increased after stroke onset, and 
immune cells, especially monocytes/macrophages and T-lymphocytes, 
existed in stroke lesions and related to exaggerate brain damage.
Epidemiological studies have shown that elevated leukocyte count was 
associated with the risk for 1st time myocardial infarction and IS [10-12] 
and the risk of recurrent myocardial infarction and IS in a high-risk 
population [13]. These observations indicate that inflammatory events 
that occur in stroke patients increase the risk of stroke recurrence. 
Studies showed that these inflammations occurred before stroke onset. 
Plasma levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), 
sICAM-1, sE-selectin, and MCP-1 were also elevated in patients with 
essential hypertension in the absence of other diseases [14-17]. 
However, anti-inflammatory strategies were shown to suppress the 
incidence of stroke. Thus, it has been suggested that inflammation might 
be a risk factor for stroke. Therefore, it is important to find the role of 
inflammation, especially monocytes/macrophages, in IS. It was found 
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that monocytes increase in peripheral blood level after IS, then travels 
to the brain where it blocks a blood vessel (Embolus) and contributes to 
the expansion of the ischemic lesion [3,18]. Lymphocyte/monocyte ratio 
(LMR) is a new indicator of the inflammation response and is also found 
to involve in many types of cancers [19,20]. Besides, low LMR levels are 
found to be closely related to the progress of coronary artery disease [21]. 
Different studies showed low LMR levels after acute IS (AIS) [22]. It has 
revealed that some of the white blood cell subtypes are associated with 
mortality due to cerebrovascular diseases [23]. However, the correlation 
of LMR with mortality in patients with AIS needs further studies. Several 
studies investigated the relationship between peripheral leukocytes 
and stroke outcomes too [24-27]. However, most of such studies were 
focused on neutrophil or a neutrophil-lymphocyte ratio (NLR) and were 
not based on the concept of stroke-induced immunosuppression. Hence, 
we hypothesized that the LMR of peripheral blood could be an indicator 
to represent the change in the peripheral immune system after stroke. 
To confirm our hypothesis, we evaluated whether LMR and other ratios 
such as NLR and neutrophil-to-monocyte ratio (NMR) are associated 
with the risk of stroke patients with AIS. We collected complete blood 
counts (CBC) counts for stroke patients and control groups including 
monocytes, lymphocytes, neutrophils, and platelets. We have compared 
each of the values between the two groups. The ratios of all these 
components were also calculated to confirm which value/s or/and 
ratio/s of these blood components is associated with the risk of stroke 
and to confirm whether LMR and other ratios such as NLR and NMR 
are a significant marker with AIS. Subsequently, this study aimed to 
retrospectively compare the LMR values between patients with IS and 
control and to determine the correlation of LMR in patients with IS and/
or any other components correlations. As far as we know, our study is 
the first in Palestine to study the association between the LMR and the 
outcome of AIS. The percentages of these blood components and the 
platelet counts in stroke patients were also evaluated. The parameters of 
these components; cell counts, ratios, and percentages, were evaluated 
and discussed in this research to determine which one of these values is 
the most potential index in the diagnosis of patients with IS.
METHODS
We have reviewed and evaluated 1000 files of patients admitted to intensive 
care units between January 2017 and March 2020 at Alia Governmental 
Hospital in Hebron-Palestine. Patients were included in our study if they 
have met all of the following inclusion criteria: (1) Lacunar stroke and AIS, 
(2) within 24 h from stroke onset, and (3) strokes in the anterior circulation. 
Patients with the following conditions were excluded: (1) Autoimmune 
diseases, (2) cancers, (3) hematologic disorders, (4) infectious diseases 
(5) taking the immunosuppressant, and (6) other cardiovascular diseases. 
We have reviewed patients’ files after getting approval from the Palestinian 
Ministry of Health (MOH). The patients’ identities remained confidential 
and the data used for research purposes only.
Only 87 patients were found to meets our inclusion criteria and included 
in the study and a total of 913 patients were excluded. Besides, CBC 
data of a total of 95 patients were also collected randomly from Al-
Waed Private Lab in Hebron district, and were considered as healthy 
individuals (HI); that is, the control group. HIs were selected as those 
with a routine CBC checkup and healthy with a non-recognized disease, 
especially stroke or/and its related diseases or stroke consequences 
diseases. The data for patients and control group were introduced to the 
excel program 2010 version to facilitate reading and analysis. The data 
have been divided and separated into rows and columns according to 
the research requirements. GraphPad Prism version (8.3.4.) was used to 
analyze the data. The parameters of white blood components; cell counts, 
ratios, and percentages, were evaluated and discussed in this research 
study. Besides, the platelet counts were collected for both groups.
RESULTS
Different types of white blood cells; monocytes, lymphocytes, and 
neutrophils for stroke and healthy patients, were collected and 
compared. Furthermore, the platelet count was determined. The 
values of these components; cell counts, ratios, and percentages, were 
evaluated and discussed in this research to determine which one is the 
most potential index in the diagnosis of patients with IS. It was found 
a marked significant decrease in the monocytes counts in all stroke 
patients (100–1500 cell/ul) compare to monocytes counts in the 
healthy donors (310–1740 cell/ul). Lymphocytes were also significantly 
decreased among all stroke patients (300–8600 cells/ul) compare to HI 
(910–9000 cells/ul). There was no significant increase in neutrophils in 
stroke patients. The ratios of neutrophils to monocytes and neutrophils 
to lymphocytes in stroke patients were compared too and evaluated. 
The results showed a markable elevated neutrophil ratio compare to 
monocytes and lymphocytes in all stroke patients. The platelet counts in 
stroke patients were found less compared to HIs. Other ratios of blood 
components were also evaluated. Out of 1000 patients, 87 patients were 
included in this study, after the exclusion of 913 patients according to the 
exclusion criteria shown in the methods section. A comparison between 
leukocyte counts and their respective ratios was evaluated too. It was 
found that the Lymphocyte/monocyte ratios were lower in patients with 
acute Ischemic stroke (AIS); while the neutrophils’ percentages to either 
lymphocytes or monocytes were higher in the patients’ group; these were 
the most significant parameters in our study. However, the results divided 
according to the type of blood components and evaluation methods; that 
is, cells count, ratios, and percentages of the components as following:
CBC of monocytes and T-lymphocytes cells in stroke patient versus 
healthy donors
Our preliminary results showed that the monocytes in the presence 
of high-molecular-weight heparin have a positive impact on MMP-
9 regulation [27]. Thus, it was reasonable to investigate the role of 
monocytes in stroke patients compared to HI. The initial result of this 
study showed that there was a markable significant decrease in the 
monocytes counts in all stroke patients (100–1500 cell/ul) compare 
to the monocytes counts in the healthy donors (310–1740 cell/ul), as 
shown in Fig. 1. Thus, this supports the assumption that monocytes 
appear to be the major key player in the pathophysiology of stroke. To 
investigate the other immune cell types which might also have an impact 
on stroke, we determined the cell counts of lymphocytes and neutrophils 
on the presence or absence of stroke. As expected, we could reveal that in 
the presence of stroke, lymphocytes are significantly decreased, as shown 
in Fig. 2. This is further confirmation that other immune cell types have 
a role in stroke. The decrease of lymphocytes is considered a significant 
decrease among all stroke patients in which it varies between 300 and 
8600 cell/ul in stroke patients and between 910 and 9000 cell/ul in HIs, 
as shown in Figs. 1 and 2. When the cell count of neutrophils of stroke 
patients and healthy individuals were compared; it was noticed that the 
Fig. 1: Significant reduction of monocytes whole blood samples of 
stroke patients. The cell count of monocytes in the corresponding 
patients was compared by the unpaired t-test with Welch 
correction. Results were considered significant at p≤0.0001
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cell count of neutrophils in the blood samples of the patients is slightly 
increased compared to the healthy group, as shown in Fig. 3, thus there 
was no significant difference in neutrophils between the two groups.
Comparing the monocytes and lymphocytes in the HIs with the normal 
range values; it is shown that once the person is in a healthy state, the 
count of the monocytes is within the normal range, which is between 
200 and 950 cell/ul, and the lymphocytes count is also in the normal 
state, which is between 850 and 3500 cell/ul, as shown in Figs. 1 and 
2. Thus, an adverse effect on these two cell counts happened during the 
stroke, this clarifies that there is a relationship between both cell types 
themselves and the stroke. However, we also compared the cell counts 
between both neutrophils/monocytes and neutrophils/T-lymphocytes 
to confirm if there are any relationships between these components in 
stroke patients or to exclude the neutrophils. Thecomparison results 
between both cell types monocytes/neutrophils and lymphocytes/
neutrophils ratios are summarized in Figs. 4 and 5. It was found that 
the neutrophils ratios were markedly elevated in all stroke patients 
compared to monocytes (Fig. 4) and lymphocytes (Fig. 5). As expected, 
we could not reveal any significant effects after comparing the 
Fig. 2: Significant reduction of lymphocytes in whole blood 
samples of stroke patients. The cell count of lymphocytes in the 
corresponding patients was compared by the unpaired t-test 
with Welch correction. Results were considered significant at 
p≤0.0001
Fig. 3: Non-significant increase of neutrophils in whole blood 
samples of stroke patients. The cell count of neutrophils in the 
corresponding patients was compared by the unpaired t-test 
with Welch correction. Results were considered significant at 
p≤0.1171
neutrophils/monocytes cell counts ratio (Fig. 6) or neutrophils and 
T-lymphocytes cell counts ratio (Fig. 7), this supports the assumption 
that; in the pathophysiology of stroke, the monocytes is a key player in 
addition to its connection to lymphocytes. The cell count of platelets in 
the blood samples of the stroke patients is slightly decreased compared 
to the healthy group, as shown in Fig. 8, thus no significant difference 
in platelet between the two groups. However, surprisingly on further 
investigation, there were new promising results concerning the ratio of 
platelets and neutrophils counts. As the results of the neutrophils did 
not have any regulatory effect on monocytes or lymphocytes, while it 
has significant effects in the platelet (data not shown); more studies 
will be carried out in platelets to verify this.
Monocytes, lymphocytes, and neutrophil ratio as a predictor tool 
in stroke
Since there is an interaction between monocytes and other immune 
cells further analysis was carried out to reveal if the immune cell counts 
could be a better diagnostic or prognostic approach or whether certain 
Fig. 4: Comparison between monocytes and neutrophils ratios 
among stroke. Both cell ratios in the corresponding patients were 
compared by the unpaired t-test with Welch correction. Results 
were considered significant at p≤0.0001. F-test was used to 
compare variances in which results were considered significant 
at p≤0.0001
Fig. 5: Comparison between lymphocytes and neutrophils ratios 
among stroke. Both cell ratios in the corresponding patients 
were compared by the unpaired t-test with Welch correction. 
Results were considered significant at p≤0.0001. F-test was used 
to compare variances in which results were considered non-
significant at p≤0.1113
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immune cells could be considered as a better predictive approach. Thus, 
the ratio between monocytes and neutrophils in HIs and stroke patients 
was calculated and found that there is a slight significant decrease 
between monocytes/neutrophils ratio in stroke patients in contrast 
to HI at p≤0.0001, respectively. The ratio of monocytes/neutrophils 
was between 0.01–0.2% in stroke patients and 0.01–0.5% in HIs, as 
shown in Fig. 9. When the ratio between monocytes/lymphocytes was 
determined; a massive significant increase in all stroke patients 0.15–
0.8% and 0.09–0.5% in HIs existed, as shown in Fig. 10. Moreover, to 
support our results, the ratio of lymphocytes/monocytes (Fig. 11) or 
lymphocytes/neutrophils (Fig. 12) was also calculated for both studied 
groups. The results showed that there is a decrease in the ratios of both 
lymphocytes/monocytes (0.3–25%) or lymphocytes/neutrophils (0.03–
1.2%), which was considered a significant decrease in lymphocytes/
neutrophils but a non-significant decrease in lymphocytes/monocytes.
To elucidate the role of neutrophils if they could be a better predictive 
tool of stroke, neutrophils-monocytes percentage ratio (NMR) was 
calculated, as shown in Fig. 13. It revealed that neutrophils have a 
role in the prediction of stroke similar to monocytes and could be 
used as s supportive predictor, as the neutrophils/monocytes ratio 
was significantly increased (Fig. 13) in contrast to neutrophils/
lymphocytes (Fig. 14). This shall support our assumption that 
monocytes are the key players in stroke disease. Thus, the predictive 
tool of stroke is dependent initially on monocytes cell counts, and the 
second parameter is lymphocytes, which show a kind of adverse effect. 
As previously mentioned and shown in Figs. 6 and 7, neutrophil cell 
counts are increased non-significantly in stroke patients in contrast to 
monocytes cell count which shows a massive significant increase in all 
stroke patients. Interestingly, we could reveal a significant reduction in 
the neutrophils/lymphocytes/platelet ratio (NLPR) in stroke patients 
(Fig. 15).
Investigating the prevalence of monocytes ratio among stroke and 
HI showed that the majority of stroke patients had a monocytes ratio 
between 5.1–10% and this represented 37.2% of the total stroke 
Fig. 6: Lymphocytes versus neutrophils in stroke patients. Cell 
counts for the corresponding stroke patients were compared 
by the unpaired t-test with Welch correction. Results were 
considered significant at p≤0.0001. F-test was used to compare 
variances in which results were considered significant at 
p≤0.0078
Fig. 8: Platelets count in stroke patients. Cell counts for the 
corresponding stroke patients were compared by the unpaired 
t-test with Welch correction. Results were considered significant 
at p≤0.0011. F-test was used to compare variances in which 
results were considered non-significant at p≤0.3034
Fig. 7: Monocytes versus neutrophils in stroke patients. Cell 
counts for the corresponding stroke patients were compared 
by the unpaired t-test with Welch correction. Results were 
considered significant at p≤0.0001. F-test was used to compare 
variances in which results were considered significant at 
p≤0.0010
Fig. 9: Monocyte/neutrophils ratio a negative prediction tool 
among stroke patients. The ratio of the corresponding studied 
groups was compared by the unpaired t-test with Welch 
correction. Results were considered significant at p≤0.0001. 
F-test was used to compare variances in which results were 
considered significant at p≤0.0001. Mann–Whitney U-test was 
significant at p≤0.0001
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patients’ profiles (32 patients), as shown in Table 1. The range 
between 0.1 and 5% represented 34.8% of the stroke patient profiles 
(30 patients) which is the second common monocytes ratio (Table 1), 
10.1–15% is 16% of the stroke patient profiles (Table 1). The ratio of 
monocytes between 15.1–20% was the least common one in stroke 
patients (Table 1). Among HIs, a monocytes ratio between 0.1 and 
5% was the most common ratio which is in 98% of HI; this ratio is the 
normal ratio of monocytes in their CBC (Table 1).
Table 2 shows the lymphocytes ratios; as the ratio between 30.1 and 35 
was the most common ratio interval in which 17.2%, 15 patients of the 
total stroke CBC reports, the ratio between 10.1 and 15 was the second 
group ratio interval with 14.9%. Lymphocytes ratio among stroke 
patients with the ratios interval 21.1–25, and 25.1–30, was the third 
distributed intervals with a total of 12.6% of the total stroke patients’ 
data. Concerning the lymphocytes ratio in HIs, as represented in Table 2, 
the majority of the HIs had a lymphocytes ratio in the interval between 
0.1 and 5 which represented 84.21% of the total HIs CBC reports. In 
addition, the interval ratio between 5.1 and 10 was only in 15.79% of 
CBC reports of the total HI.
DISCUSSION
Stroke is a major cause of morbidity and mortality worldwide. Stroke is 
a leading problem worldwide and Palestine has high cases of mortality 
due to the stroke and its complications such as a sudden heart attack, 
blood clot, thrombus formation, and embolus formation. A stroke can 
sometimes cause temporary or permanent disabilities, depending 
on how long the brain lacks blood flow and which part was affected. 
Complications may be neurological and psychological, which include 
paralysis or loss of muscle movement, difficulty talking or swallowing, 
memory loss or thinking difficulties, emotional problems, pain, changes 
Fig. 10: Monocyte/lymphocytes ratio a positive prediction 
tool among stroke patients. The ratio of the corresponding 
studied groups was compared by the unpaired t-test with Welch 
correction. Results were considered significant at p≤0.0001. 
F-test was used to compare variances in which results were 
considered significant at p≤0.0001. Mann–Whitney U-test was 
considered non-significant at p≤0.4385
Fig. 11: Lymphocyte-monocyte ratio a non-useful prediction 
tool among stroke patients. The ratio of the corresponding 
studied groups was compared by the unpaired t-test with Welch 
correction. Results were considered significant at p≤0.6463. 
F-test was used to compare variances in which results were 
considered non-significant at p≤0.2194. Mann–Whitney U-test 
was non-significant at p≤0.5097
Fig. 12: Lymphocyte-neutrophil ratio a negative prediction 
tool among stroke patients. The ratio of the corresponding 
studied groups was compared by the unpaired t-test with Welch 
correction. Results were considered significant at p≤0.0001. 
F-test was used to compare variances in which results were 
considered non-significant at p≤0.0001. Mann–Whitney U-test 
was significant at p≤0.0001
Fig. 13: Neutrophil-monocyte ratio a positive useful prediction 
tool among stroke patients. The ratio of the corresponding 
studied groups was compared by the unpaired t-test with Welch 
correction. Results were considered significant at p≤0006. F-test 
was used to compare variances in which results were considered 
non-significant at p≤0.0001. Mann–Whitney U-test was significant 
at p≤0.0001
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Fig. 14: Neutrophil-lymphocyte ratio a positive useful prediction 
tool among stroke patients. The ratio of the corresponding 
studied groups was compared by the unpaired t-test with Welch 
correction. Results were considered significant at p≤0001. F-test 
was used to compare variances in which results were considered 
non-significant at p≤0.0001. Mann–Whitney U-test was significant 
at p≤0.0001
Fig. 15: Neutrophil/lymphocyte x platelets ratio a useful 
prediction tool among stroke patients. The ratio of the 
corresponding studied groups was compared by the unpaired 
t-test with Welch correction. Results were considered significant 
at p≤0001. F-test was used to compare variances in which results 
were considered non-significant at p≤0.0001. Mann–Whitney 
U-test was significant at p≤0.0001
Table 1: Prevalence of monocytes ratio among stroke and healthy donors
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in behavior, and self-care ability [28-30]. In a healthy state, the body’s 
immune cells are always the first line of defense in the era of stroke. The 
immune system is involved in all stages of stroke, from the pathogenesis 
of risk factors to neurotoxicity, to tissue remodeling and repair. The 
IS starts in the blood vessels, where arterial occlusion results in 
hypoxia, reactive oxidative species production, and changes in shear 
stress across the lumen wall. In clinical practice, high-sensitivity CRP 
and erythrocyte sedimentation rate (ESR) are the most widely used 
inflammatory markers. The NLR, neutrophil-to-monocyte (NMR), LMR, 
and platelet-to-lymphocyte ratio (PLR) are reported to be inflammatory 
biomarkers in stroke patients [31,32].
The pathophysiology of stroke is complex and involves numerous 
processes, including energy failure, loss of cellular ion homeostasis, 
acidosis, increased intracellular calcium levels, excitotoxicity, free 
radical-mediated toxicity, generation of arachidonic acid products, 
cytokine-mediated cytotoxicity, complement activation, disruption of 
the blood–brain barrier (BBB), activation of glial cells, and infiltration 
of leukocytes. However, different immune cell interacts together to fight 
such a battle, whether it is due to genetics, risks factors, coagulation 
state, or any other complication or disease that can lead to stroke and 
its consequence complications [33]. The preliminary work of our group 
studied the impact of different anticoagulants on the regulation of 
matrix metalloproteinase 9, the cellular and molecular effect of these 
anticoagulants on the regulation of MMP-9. It was initially induced from 
the monocytes in in vitro experiments, which performed on different 
cell lines as THP-1; which mimics the monocytes, and Jurkat cell which 
mimics T-lymphocytes in humans. The preliminary finding showed that 
there was an interaction between both cells and they are dependent on 
the other [27]. This gave us attention to investigate the role of immune 
cells including monocytes in stroke patients compared to HI. The 
calculation of immune cell ratios is considered to be simple, cheap, and 
non-invasive as a tool for the diagnostic or prognostic markers in stroke, 
thus investigating the immune cell distribution could presumably 
provide insights into the disease progression. Therefore, to extend our 
preliminary work, we studied the effect of such immune cells in vivo, 
concentrating mainly on monocytes and lymphocytes. Therefore, we 
focused on this research study in the analysis of the CBC reports for 
stroke patients and compared them with healthy donors. According 
to our knowledge, this study so far is the first one in Palestine, which 
studies the relationship of the different components of the white cell 
in stroke patients. It was found that there was a significant reduction in 
monocyte cell counts in all stroke patients group, and this reduction is 
always supported by a marked significant increase in the lymphocytes 
counts. From our point of view, it seems that the major monocytes 
which already distributed in the bloodstream; once there is a stroke, 
these monocytes travel from the bloodstream into specific macrophages 
either M1 or M2, this explained why there was a significant decrease 
in the monocytes cell counts in the bloodstream of all stroke patients. 
In our research study, we did not investigate which type of monocytes 
involved in the stroke; whether it is the classical or the non-classical 
forms. Therefore, it is conceivable to speculate the type of monocytes, 
as some studies had found that in the stroke, some kind of monocytes 
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is increased [33], while other studies reported that the increase of 
monocytes level during stroke could be due to the presence of a stroke 
associated infection or to severe strokes [34].
The platelet cells count from the CBC reports of both groups was 
determined and compared. Interestingly, the platelet cell counts were 
significantly decreased among stroke patients, although it is still 
considered within the normal range. In all the stroke patients, the 
decrease was more toward the lower limit of the normal range, in 
contrast to HI as their platelet cell counts were within different ranges 
of the normal range. Since the platelets are among the major component 
of blood and responsible to prevent any hemorrhage, the platelets 
count in stroke patients was found to be more toward the lower limit 
of the normal range as mentioned; this further indicates the risk for 
thrombocytopenia (i.e. low platelets counts) state or due to the presence 
of pseudo-transient thrombocytopenia. This could be an actual indicator 
for the prediction of the stroke, but further research studies should be 
carried out to confirm this finding; due to the less knowledge about the 
proper ways of blood sample collection of stroke patients, since most of 
the stroke samples are collected in EDTA tubes, which is considered an 
in vitro error and could impact the count of platelets in the sample [35]. 
Therefore, we may recommend some further studies to be conducted 
using a different type of anticoagulant for stroke patients, since in the 
previous studies of our group, we showed that pre-analytics play a key 
role in the process of determination of the MMP-9 concentration and 
it could have similar effects in the analysis of stroke patients blood 
samples [36]. Furthermore, it is further recommended to measure the 
count of platelets before any management or treatment thrombolysis of 
stroke patients. According to our knowledge, this is the first study that 
checks the role of different parameters in the inflammations specifically 
the stroke and could be used as a tool in the prediction and progress 
of stroke. On the other hand and interestingly, our results showed that 
among the corresponding patients; the lymphocytes were elevated in 
comparison to monocytes in stroke patients, but were significantly 
lower in contrast to the lymphocytes counts in the healthy group. 
Our finding was consistent with another finding which showed that 
the presence of stroke may induce a dramatic loss of lymphocytes 
especially the T-lymphocytes [37], furthermore, the post-stroke 
induces also a further loss of T-lymphocytes, this due to the immune 
depression fact [38]. For the 1st time, we showed that another immune 
cell (i.e. neutrophils) was slightly elevated among stroke patients, 
although this elevation is considered a non-significant elevation, still, 
there was an increase in comparison to the HIs, this might contribute to 
the fact that within the minutes of the stroke occurrence, the first line 
of the immune cells is the neutrophils, which are recruited to the brain, 
therefore, it is predictable to find a transient increase in neutrophils cell 
counts [39], but this cell count non-significantly increased.
Concerning our study finding, MNR was shown to be a kind of negative 
prediction tool among stroke patients since this ratio between both 
monocytes and neutrophil cell types was significantly decreased 
in contrast to the same cell types in HIs. Moreover, we showed that 
MLR is markedly and significantly elevated in all stroke patients, this 
indicated that among the pathophysiology of stroke; both cell types 
(monocytes and lymphocytes) have an association between them, 
which is shown to be a kind of positive prediction tools among stroke 
patients. A retrospective study has shown that MLR is associated with 
carotenoid stenosis in ischemic patients [40]. Unexpectedly, LMR was 
a non-useful prediction tool among our studied group, in which there 
was no significant effect between both cell ratios, conversely, some 
studies showed that LMR was an independent factor in the severity of 
the stroke and its consequences [38]. Among our results, LNR showed a 
negative prediction tool among stroke patients, therefore, this indicates 
that among these; there is an association between these cell types and 
the stroke. Surprisingly, we revealed that the NMR was a positive useful 
prediction tool among these stroke patients. In which it was markedly 
increased with about 2–3-fold induction; therefore, this supports our 
assumption that the monocytes are a key player in the stroke. Besides, 
the NLR is found to be a positive useful prediction tool among stroke 
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patients. Our finding was consistent with pilot studies that determined 
the neutrophils-to-lymphocytes and lymphocytes-to-monocytes ratios, 
which showed that the stroke patients with higher NLR are expected 
to have a more severe stroke [41] and the association of NLR and 
MNR can predict the functional outcome of stroke after mechanical 
thrombectomy [42]. From our study, we revealed a new promising 
tool that is based on measuring the NLPR. Presumably, this approach 
could be a better tool for diagnosis, mono, and prognosis of stroke; 
since our study showed that there was a marked significant decrease 
in the NLPR; once we divided the total count of neutrophils on the 
lymphocytes times platelets count. This predictor is most likely to be a 
novel prognosis tool in stroke patients. Our study confirmed that some 
tools could be potentially used as positive predictor tools among stroke; 
in which they are increased in addition to others. Besides, others could 
be used as a kind of negative prediction tool; in which they decreased 
in stroke patients. Therefore, these kinds of markers are impressive 
and can be added to the panel of stroke markers or inflammatory 
research; in addition to its correlation with immune cells. Thus, the 
utility of these could provide informative knowledge to the profiles of 
patients with stroke. Further studies that focus on the type of different 
kinds of monocytes, lymphocytes, and neutrophils are still needed to 
confirm if these tools contribute as the same prediction effect among 
them. Besides, our research study has some limitations. First, this 
study is a retrospective single-site study, a prospective, and multisite 
cross-sectional research should be carried out. Second, the relationship 
between MLR and the incidence of major adverse cardiac and cerebral 
vascular events and death was not explored in this study. Thus, further 
study is needed to be performed in the future.
CONCLUSION
The immune system has a key role in brain injury. A better understanding 
of the interactions between the immune system and the brain can aid 
physicians who care for patients with stroke and other forms of central 
nervous system injury. The main finding of this research study was 
that NLR in stroke patients was markedly high. Therefore, patients 
with higher NLR may be expected to have a more severe stroke. The 
monocytes/lymphocytes percentage ratio is also an independent risk 
factor of stroke. It is demonstrated that patients with stroke have lower 
lymphocytes and higher monocyte counts, and therefore, lower LMR 
values compared to the control group. Our study found that MLR was 
significantly correlated with IS and LMR is associated with functional 
outcomes in patients with stroke. Therefore, MLR might be considered 
a potential index in the diagnosis of patients with IS. The link between 
stroke severity and NLR and MLR deserves further study with large 
sample size.
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